Surgepays is trading at $0.14, down 5.37%, with no clear company-specific catalyst identified for the September 30 decline.
- The company news listing shows no release dated September 30.
- The latest listed releases were the September 17 joint-venture LOI and September 10 asset sale; neither establishes a reason for the session’s drop.
- Broader indexes are higher, moving in the opposite direction.